Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis
Osteoporosis International, 10/30/09
Procianoy F et al. – A diagnosis of orbital inflammatory disease was made, and the patient was treated with high–dose oral steroids (prednisone 80 mg/day) tapered along 6 weeks. The symptoms and the swelling reduced progressively after initiating oral prednisone, and after 12 days, there was complete resolution of the condition. The patient remained symptom free and had no remission after the treatment interruption.
Related Articles
Update on thyroid eye disease and management
Clinical Ophthalmology, 10/19/09
Relevance Score: 80%
Successful Treatment of Idiopathic Orbital Inflammatory Disease with Leflunomide: A Case Report
Southern Medical Journal, 10/08/09
Relevance Score: 78%
Novel Diagnostic and Prognostic Modalities in Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/17/09
Relevance Score: 70%
Pathogenesis of inflammatory bowel disease (IBD)
The Internet Journal of Gastroenterology, 11/13/09
Relevance Score: 70%
Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history
Expert Review of Gastroenterology & Hepatology, 10/13/09
Relevance Score: 70%
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
The Role of Quantitative Bone Scanning in the Assessment of Bone Turnover in Patients with Charcot Foot
Diabetes Care, 11/25/09
Assessment of Regional Changes in Skeletal Metabolism Following 3 and 18 Months of Teriparatide Treatment
Journal of Bone and Mineral Research, 11/25/09
Relationship Between Genotype and Skeletal Phenotype in Children and Adolescents With Osteogenesis Imperfecta
Journal of Bone and Mineral Research, 11/25/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: A prospective study
Osteoporosis International, 11/25/09
Treatment of osteoporosis: Recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity
Osteoporosis International, 11/25/09
Urinary deoxypyridinoline is a BMD-independent marker for prevalent vertebral fractures in postmenopausal women treated with glucocorticoid
Osteoporosis International, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


